Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
572 News Items found
MSK Awards & Appointments January 2023
MSK Awards & Appointments January 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Robin Bankins
Feature
FDA Approves First Treatment for Patients With All Forms of Histiocytosis

Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.
detail shot of a scientist pipetting in a lab
MSK Research Highlights, January 20, 2023

New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.
Dr. John Chodera in his lab
Shooting for the Moon: How the Drive To Tackle COVID-19 Will Speed Up Cancer Drug Discovery

During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.
three tobacco hornworm caterpillars held in a scientist's hand
Move Over, Mice: Caterpillars Could Replace Some Mammals in the Study of Human Disease

How scientists are working to develop nonmammalian alternatives that could reduce the number of rodents used in biomedical research.
Postdoctoral researcher Yanan Ma, PhD
Go Fish: Why MSK Researchers Use Zebrafish To Study a Cancer-Linked Inflammation Pathway

A study led by postdoctoral researcher Yanan Ma from the lab of cell biologist Philipp Niethammer shows why diversity also matters in model animal research.
MSK Awards & Appointments December 2022
MSK Awards & Appointments December 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
detail shot of laboratory slides
MSK Research Highlights, December 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.
Person in white lab coat using a pipette with a tiny test tube.
Top Cancer Research Advances at MSK in 2022

Read about some of the biggest scientific discoveries made by MSK researchers in 2022.
Blood samples being prepared for a centrifuge
MSK Research Highlights, ASH Annual Meeting 2022

Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.